We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

70 hedge funds and large institutions have $9.92M invested in T2 Biosystems, Inc in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $280K | Put options by funds: $177K

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

4% less funds holding

Funds holding: 73 → 70 (-3)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

53% less capital invested

Capital invested by funds: $21.1M → $9.92M (-$11.2M)

Holders
70
Holders Change
-3
Holders Change %
-4.11%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
15
Reduced
11
Closed
12
Calls
$280K
Puts
$177K
Net Calls
+$103K
Net Calls Change
+$12K

Top Buyers

Rank Fund Capital Flow
1
GS
Gagnon Securities
New York
+$170K
2
VF
Virtu Financial
New York
+$136K
3
Citadel Advisors
Citadel Advisors
Florida
+$108K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$104K
5
Jane Street
Jane Street
New York
+$62.6K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$1.74M
2
Millennium Management
Millennium Management
New York
-$497K
3
N
Natixis
France
-$491K
4
Principal Financial Group
Principal Financial Group
Iowa
-$313K
5
GCP
GSA Capital Partners
United Kingdom
-$152K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$31K +$38.3K +11 +1,100%
Osaic Holdings
27
Osaic Holdings
Arizona
$29K -$76.5K -22 -67%
TSS
28
Two Sigma Securities
New York
$29K +$20.9K +6 +120%
BBVA
29
Banco Bilbao Vizcaya Argentaria
Spain
$29K +$38.3K +11 New
CA
30
Continuum Advisory
Idaho
$26K – – –
PFGIA
31
Patriot Financial Group Insurance Agency
Massachusetts
$26K – – –
UBS Group
32
UBS Group
Switzerland
$26K +$31.3K +9 +900%
Charles Schwab
33
Charles Schwab
California
$25K – – –
RJA
34
Raymond James & Associates
Florida
$21K +$3.48K +1 +14%
FCMT
35
Founders Capital Management (Texas)
Texas
$21K +$6.96K +2 +33%
HF
36
HRT Financial
New York
$19K +$27.8K +8 New
VFA
37
Valeo Financial Advisors
Indiana
$18K – – –
AWM
38
AE Wealth Management
Kansas
$18K +$6.96K +2 +40%
BAM
39
Brave Asset Management
New Jersey
$14K – – –
Ameriprise
40
Ameriprise
Minnesota
$13K -$111K -32 -86%
LPL Financial
41
LPL Financial
California
$12K – – –
Victory Capital Management
42
Victory Capital Management
Texas
$12K – – –
AI
43
Atom Investors
Texas
$12K +$17.4K +5 New
IF
44
Ironwood Financial
Arizona
$11K – – –
WP
45
WealthPLAN Partners
Nebraska
$11K – – –
Cambridge Investment Research Advisors
46
Cambridge Investment Research Advisors
Iowa
$10K – – –
TCM
47
Traynor Capital Management
Pennsylvania
$10K – – –
US Bancorp
48
US Bancorp
Minnesota
$10K – – –
JP Morgan Chase
49
JP Morgan Chase
New York
$9K -$24.3K -7 -64%
FWM
50
Focused Wealth Management
New York
$9K – – –
1
2
3 4

TTOO Hedge Fund Activity: Q4 2021 in Review

70 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2021, worth a combined $9.92M — down 53% from $21.1M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of TTOO and 9 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 15 added.

The largest buyer was Gagnon Securities, adding an estimated $170K. The largest seller was Goldman Sachs, cutting an estimated $1.74M.

  • 70 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2021, down from 73 in Q3 2021.
  • Funds reported $9.92M of T2 Biosystems, Inc stock for Q4 2021, down 53% quarter-over-quarter.
  • 9 funds opened new T2 Biosystems, Inc positions in Q4 2021 and 12 closed out, a net change of -3 holders.
  • The largest T2 Biosystems, Inc buyer in Q4 2021 was Gagnon Securities, an estimated $170K added.
  • The largest T2 Biosystems, Inc seller in Q4 2021 was Goldman Sachs, an estimated $1.74M sold.

Based on aggregated 13F filings for Q4 2021.